ALAB

Broadcom stock is near highs ahead of earnings, along with other hot tech stocks like Credo Technology and fiber optic leader Ciena.

Credo Technology Group Holding Ltd CRDO is scheduled to report fourth-quarter fiscal 2026 results on June 1, after the closing bell. The Zacks Consensus Estimate for the bottom line for the to-be-reported quarter stands at $1.03, indicating a 194.3% year-over-year surge. The estimate has remained unchanged in the past 30 days. The Zacks Consensus Estimate for total revenues is pinned at $430.08 million, implying a 153% increase. For the fiscal fourth quarter, CRDO expects revenues to be between $425 million and $435 million. Credo’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 31.6%. Image Source: Zacks Investment Research Let us see how CRDO is expected to fare in terms of revenues and earnings this time. Our proven model does not conclusively predict an earnings beat for CRDO this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter. CRDO has an Earnings ESP of 0.00% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here. Credo’s fiscal fourth-quarter performance is likely to have been driven by strong demand for its active electrical cables (“AEC”) and optical products, along with deeper engagement with hyperscalers. On the last earnings call, management noted that revenues more than doubled from fiscal 2024 to 2025, and the company expects the metric to triple from fiscal 2025 to 2026, with management putting the number just north of $1.3 billion for fiscal 2026. This implies that Credo will have achieved more than six times the revenue growth within two years. Three hyperscalers each contributed more than 10% of total revenues in the last reported quarter, reflecting strong adoption of Credo’s high-reliability AEC solutions. Credo has also secured a fifth hyperscaler customer, further strengthening its position within the global cloud ecosystem. Beyond the traditional hyperscalers, Credo is also seeing increasing demand from emerging Neocloud providers. AECs remain Credo’s fastest-growing product line and the primary revenue driver as these now play an increasingly critical role in AI-driven networking deployments. According to Credo...

Marvell Technology, Inc. MRVL is scheduled to report first-quarter fiscal 2027 results after market close on May 27, 2026. Marvell Technology anticipates revenues of $2.40 billion (+/- 5%) for the first quarter of fiscal 2027. The Zacks Consensus Estimate for MRVL’s fiscal first-quarter revenues is pegged at $2.40 billion, indicating year-over-year growth of 27%. For the fiscal first quarter, the company expects non-GAAP earnings of 79 cents (+/- $0.05) per share. The Zacks Consensus Estimate for MRVL’s fiscal first-quarter earnings is pegged at 80 cents per share, reflecting a 29% increase year over year. The consensus mark for earnings has remained unchanged over the past 60 days. Image Source: Zacks Investment Research In the trailing four quarters, Marvell Technology’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 1%. Marvell Technology, Inc. price-eps-surprise | Marvell Technology, Inc. Quote Our proven model does not conclusively predict an earnings beat for Marvell Technology this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here. Though Marvell Technology currently carries a Zacks Rank #3, it has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter. You can see the complete list of today’s Zacks #1 Rank stocks here. MRVL’s data center business is likely to have remained the primary growth driver in the first quarter of fiscal 2027, supported by accelerating AI infrastructure spending and strong bookings across its interconnect, switching and custom silicon portfolio. MRVL’s bookings are accelerating at a record pace and robust cloud CapEx trends are driving strong demand across the company’s entire data center portfolio. Marvell Technology’s data center revenues are likely to have benefited from strong demand for optical interconnects, custom AI accelerators, Ethernet switching products and XPU-attach solutions. The company expects its data center revenues to grow approximately 10% sequentially in the first quarter of fiscal 2027. Management highlighted that demand remains robust for its 800-Gig products while 1.6T solutions are ramping rapidly with multiple Tier 1 customers. MRVL’s custom bu...

In the last week, the United States market has stayed flat, yet it has seen a remarkable 25% increase over the past year with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its potential for continued success. Click here to see the full list of 187 stocks from our Fast Growing US Companies With High Insider Ownership screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Growth Rating: ★★★★★☆ Overview: Aeluma, Inc. develops optoelectronic and electronic devices for sensing, communication, and computing applications in the United States with a market cap of $488.06 million. Operations: The company's revenue is primarily derived from its Semiconductor Equipment and Services segment, which generated $5.23 million. Insider Ownership: 25.8% Earnings Growth Forecast: 68.6% p.a. Aeluma is positioned for significant growth with forecasted revenue expansion of 77% annually, outpacing the US market. Despite a volatile share price and recent net losses, its strategic focus on high-growth sectors like AI infrastructure and quantum technologies is bolstered by substantial U.S. government contracts exceeding US$4 million. The company's innovative quantum dot laser platform, supported by NASA awards, enhances its competitive edge in photonics integration. However, low projected return on equity remains a concern. Click to explore a detailed breakdown of our findings in Aeluma's earnings growth report. Our valuation report here indicates Aeluma may be overvalued. Simply Wall St Growth Rating: ★★★★☆☆ Overview: STAAR Surgical Company designs, develops, manufactures, and sells phakic implantable lenses and accessory delivery systems for the eye, with a market cap of approximately $1.40 billion. Operations: The company's revenue is primarily generated from its ophthalmic surgical products, totaling $239.44 million. Insider Ownership: 26.2% Earnings Growth Forecast: 71.6% p.a. STAAR Surgical's growth potential is underscored by its forecasted revenue increase of 11.8% annually, slightly above the US market average. Recent earnings showed significant improvement with sales reaching US$93.52 million, a substantial rise from the previous year, and a shift to n...

Over the last 7 days, the United States market has risen by 1.1%, contributing to an impressive 27% climb over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, companies that exhibit high growth potential and significant insider ownership can be particularly appealing, as they often indicate strong confidence from those closest to the business. Click here to see the full list of 181 stocks from our Fast Growing US Companies With High Insider Ownership screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Evolus, Inc. is a performance beauty company that provides products in the cash-pay aesthetic market across the United States, Canada, Europe, and Australia with a market cap of $442.54 million. Operations: The company's revenue segment focuses on delivering medical aesthetic products to the cash-pay aesthetic market, generating $301.79 million. Insider Ownership: 11.1% Earnings Growth Forecast: 66.7% p.a. Evolus, Inc. is poised for significant growth with its forecasted profitability within three years and revenue growth expected to outpace the broader US market at 14.4% annually. Recent earnings show a narrowing net loss, and the company anticipates annual revenues between US$327 million and US$337 million for 2026. The upcoming European launch of Estyme marks an international expansion in dermal fillers, potentially enhancing revenue streams despite historically volatile share prices and negative shareholders' equity concerns. Click here and access our complete growth analysis report to understand the dynamics of Evolus. Our expertly prepared valuation report Evolus implies its share price may be lower than expected. Simply Wall St Growth Rating: ★★★★★★ Overview: Upstart Holdings, Inc. operates a cloud-based AI lending platform in the United States and has a market cap of approximately $2.58 billion. Operations: The company's revenue is primarily derived from its personal lending segment, which generated $1.01 billion. Insider Ownership: 12.8% Earnings Growth Forecast: 58.5% p.a. Upstart Holdings is positioned for robust growth, with earnings projected to rise significantly at 58.5% annually, outpacing the US market. Despite a recent net loss of US$6.65 million in Q1 2026, insider activity indicates more buying than selling over...

Astera Labs, Inc. (NASDAQ:ALAB) is included among the 10 Best Stocks to Buy Now for a $1 Million Portfolio. Image by Alexsander-777 from Pixabay On May 7, Susquehanna analyst Mehdi Hosseini raised the firm’s price recommendation on Astera Labs, Inc. (NASDAQ:ALAB) to $230 from $155. It reiterated a Neutral rating on the shares. The firm said Astera Labs reported first-quarter results and second-quarter guidance above consensus estimates. Susquehanna noted that the company continues to diversify its product revenue while gaining more connectivity content per AI rack. The same day, Morgan Stanley analyst Joseph Moore raised the firm’s price target on Astera Labs to $240 from $210 and kept an Overweight rating on the stock. Moore said Astera is executing at a high level, with Scorpio helping drive near-term growth. He added that the company is benefiting from rising content per XPU, early leadership in PCIe Gen 6, and future opportunities tied to optical and custom solutions. According to the analyst, Astera “remains well positioned for sustained AI infrastructure growth.” Astera Labs, Inc. (NASDAQ:ALAB) designs and delivers semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform combines semiconductor technology, microcontrollers, sensors, and software to improve performance, scalability, and data management. While we acknowledge the potential of ALAB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Best Dividend Stocks to Buy for Steady Growth and 10 Best Robinhood Stocks to Buy According to Billionaires. Disclosure: None. Follow Insider Monkey on Google News.

The subdued stock price reaction suggests that Astera Labs, Inc.'s (NASDAQ:ALAB) strong earnings didn't offer any surprises. We think that investors have missed some encouraging factors underlying the profit figures. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'. Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking. Astera Labs has an accrual ratio of -0.35 for the year to March 2026. That indicates that its free cash flow quite significantly exceeded its statutory profit. Indeed, in the last twelve months it reported free cash flow of US$343m, well over the US$267.6m it reported in profit. Astera Labs shareholders are no doubt pleased that free cash flow improved over the last twelve months. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. As we discussed above, Astera Labs' accrual ratio indicates strong conversion of profit to free cash flow, which is a positive for the company. Based on this observation, we consider it possible that Astera Labs' statutory profit actually understates its earnings potential! And on top of that, its earnings per share have grown at an extremely impressive rate over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the...

Over the last 7 days, the United States market has risen by 1.5%, contributing to a remarkable 26% climb over the past year, with earnings forecasted to grow by 17% annually. In this flourishing environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and potential for substantial earnings expansion. Click here to see the full list of 185 stocks from our Fast Growing US Companies With High Insider Ownership screener. Let's explore several standout options from the results in the screener. Simply Wall St Growth Rating: ★★★★★☆ Overview: Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing chimeric antigen receptor cell therapy for light chain amyloidosis and immune-mediated diseases, with a market cap of $525.88 million. Operations: Revenue Segments (in millions of $): null Insider Ownership: 12.8% Earnings Growth Forecast: 63.4% p.a. Immix Biopharma is a growth-focused company with high insider ownership, currently navigating financial challenges with a reported net loss of US$10.09 million for Q1 2026. Despite this, its revenue is forecasted to grow significantly faster than the US market at 56.6% annually, driven by promising developments like NXC-201 for AL Amyloidosis. The company anticipates profitability within three years, although it has experienced substantial shareholder dilution and share price volatility recently. Get an in-depth perspective on Immix Biopharma's performance by reading our analyst estimates report here. Our valuation report here indicates Immix Biopharma may be overvalued. Simply Wall St Growth Rating: ★★★★★☆ Overview: Rumble Inc. operates a video sharing and cloud services platform across the United States, Canada, and internationally, with a market cap of approximately $2.77 billion. Operations: The company's revenue is generated from its Internet Software & Services segment, amounting to $100.62 million. Insider Ownership: 35.9% Earnings Growth Forecast: 56.8% p.a. Rumble Inc. exhibits high insider ownership and is positioned for substantial growth, with revenue forecasted to expand at 42.5% annually, outpacing the US market. Recent initiatives like the OpenClaw Starter package on Rumble Cloud highlight its innovative approach in AI infrastructure. Despite a history of volatility and fin...

Astera Labs ALAB shares have lost 0.8% since it reported first-quarter 2026 results on Tuesday. The decline can be attributed to the continued high R&D expenses and ongoing investments in acquisitions and new design centers, which have increased operating costs. Challenging macroeconomic uncertainties and stiff competition remain a headwind. Click here to check the details of ALAB's first-quarter 2026 results. However, Astera Labs shares have gained 28.6% in the year-to-date period, outperforming the broader Zacks Computer & Technology sector’s increase of 11.9% and the Zacks Internet - Software industry’s decline of 12.7% over the same time frame. The outperformance can be attributed to the strong demand for their AI connectivity products, especially the Scorpio and Aries portfolios. Image Source: Zacks Investment Research ALAB is rapidly expanding its portfolio to address the growing demands of AI infrastructure and connectivity solutions. Its product portfolio, including Scorpio, Aries, and Taurus, has been a key catalyst. The Scorpio product family, particularly the Scorpio X-Series and P-Series PCIe 6 switches, has seen strong momentum. In the first quarter of 2026, ALAB expanded its market-leading Scorpio P-Series PCIe-6 Fabric Switch family to span 32- to 320-lane configurations, enabling flexible deployment across hyperscale and AI infrastructure environments. The company also enhanced infrastructure fleet management with customer-optimized firmware and COSMOS embedded software, while expecting multi-customer shipments in the second half of 2026 and broader volume ramps in 2027. Further expanding its portfolio, ALAB recently announced the launch of the Scorpio X-Series 320-lane Smart Fabric Switch, the industry’s largest open, memory-semantic fabric switch designed for frontier AI lab workloads. The platform supports diverse accelerators through open and proprietary protocols. At the same time, innovations like Hypercast and In-Network Compute can double the collective performance of operations, reduce latency and improve token economics for agentic inference. Production ramp is expected in the second half of 2026, targeting the rapidly growing $20 billion merchant scale-up market by 2030. ALAB is benefiting from strong growth in UALink, an open standard scale-up connectivity protocol designed to address the increasing demands of AI infrastructure. U...

Astera Labs ALAB reported first-quarter 2026 non-GAAP earnings of 61 cents per share, up 84.8% year over year. The results beat the Zacks Consensus Estimate by 13.66%. Revenues totaled $308 million, up 93.4% from the year-ago quarter and surpassed the Zacks Consensus Estimate by 5.42%. Results reflected robust demand tied to the company’s PCIe 6 connectivity portfolios, which contributed more than one-third of total revenue in the quarter. ALAB’s top line increased 14% sequentially, supported by strength across signal conditioning and switch fabric offerings that enable both scale-up and scale-out connectivity in AI platforms. Management highlighted continued diversification, with multiple customers and product categories contributing to growth. PCIe Gen 6 momentum remained a central theme. The company noted it has shipped millions of PCIe Gen 6 ports to date, underscoring both portfolio maturity and the pace of adoption as AI infrastructure transitions to higher-speed interconnect standards. Astera Labs, Inc. price-consensus-eps-surprise-chart | Astera Labs, Inc. Quote Astera Labs emphasized progress in its Scorpio family, with Scorpio X-Series products beginning to ship in initial production volumes during the quarter. Management expects Scorpio X-Series shipments to rise in the second quarter, alongside initial shipments of the newly announced 320-lane Scorpio X device, before ramping up to full volume production in the second half of 2026. The company also expanded the Scorpio P-Series PCIe 6 switch family to span 32 to 320 lanes. Leadership positioned the broader Scorpio portfolio as a platform for higher-value AI fabric deployments, citing features such as Hypercast and in-network compute aimed at improving collective operations and reducing networking overhead in large-scale training and inference workloads. Non-GAAP gross margin was 76.4% in the first quarter, expanding 150 basis points year over year, primarily due to a lower mix of hardware sales within the signal conditioning portfolio. This result points to solid underlying profitability despite the ongoing product ramp and expanding portfolio. Research and development expenses surged 94.6% year over year to $125.6 million. Sales and marketing expenses increased 0.9% year over year to $21.9 million. General and administrative expenses increased 17.9% year over year to $25.8 million. The non-GAAP...

Astera Labs (ALAB) reported Q1 non-GAAP earnings late Tuesday of $0.61 per diluted share, up from $0

Record quarterly revenue of $308.4 million, up 14% QoQ and up 93% year-over-year Market-leading PCIe 6 AI fabric and signal conditioning portfolio delivered strong growth during Q1 Now shipping newly announced Scorpio™ X-Series 320-lane AI Fabric switch and expanded Scorpio P-Series PCIe 6 switch family supporting 32 to 320 lanes SAN JOSE, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced preliminary financial results for the first quarter of fiscal year of 2026, ended March 31, 2026. “Astera Labs delivered strong Q1 2026 financial results with revenue growing by 14% sequentially and 93% year-over-year to a record level of $308.4 million, driven by robust demand for our PCIe 6 portfolio,” said Jitendra Mohan, Astera Labs’ Chief Executive Officer. “Adoption of our Intelligent Connectivity Platform continues to expand with the launch and initial shipments of our new Scorpio™ X-Series 320-lane AI scale-up fabric switch, new design engagements for custom and optical solutions, and growing market share for our broad portfolio of 32 to 320 lane PCIe switches and Smart Cable Modules. We believe the opportunity ahead is significant, and we are investing to be a leader for rack-scale AI technologies in close partnership with our customers.” First Quarter of Fiscal 2026 Financial Highlights GAAP Financial Results: Revenue of $308.4 million, up 14% sequentially and up 93% year-over-year GAAP gross margin of 76.3% GAAP operating income of $61.8 million GAAP operating margin of 20.1% GAAP net income of $80.3 million GAAP diluted net earnings per share of $0.44 Non-GAAP Financial Results (excluding the impact of stock-based compensation expense, acquisition-related costs, and the income tax effects of non-GAAP adjustments): Non-GAAP gross margin of 76.4% Non-GAAP operating income of $111.7 million Non-GAAP operating margin of 36.2% Non-GAAP net income of $110.1 million Non-GAAP diluted net earnings per share of $0.61 Q1 2026 and Recent Business Highlights Announced Scorpio X-Series 320-lane Smart Fabric Switch, the largest open, memory-semantic fabric switch, purpose-built for frontier AI lab workloads. The AI fabric switch leverages open and platform specific protocols to deliver infrastructure optionality across diverse accelerators in high-r...